Stock Warrant
WARRANTRevelation Biosciences, Inc. Warrant
No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.
REVBW is Revelation Biosciences, Inc. Warrant (Healthcare) — a non-dividend-paying stock. Trading at $0.01. Capital Quality Rank: 39/100 — Stagnant mediocrity.
Stock snapshot
| Price | $0.01 |
| Market cap | — |
| Sector | Healthcare |
| Exchange | — |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 39 / 100 · Stagnant mediocrity |
| Shareholder buyback yield | 0.00% |
| Altman Z-score zone | Distress |
About REVBW
Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
Related non-dividend companies
Other non-dividend stocks investors research alongside REVBW. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is REVBW's current stock price?
REVBW (Revelation Biosciences, Inc. Warrant) is currently trading at $0.01.
Does REVBW pay a dividend?
REVBW (Revelation Biosciences, Inc. Warrant) does not currently pay a regular dividend.
What is REVBW's Capital Quality Rank?
REVBW has a Capital Quality Rank of 39/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track REVBW in DiviDrip
Add REVBW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search REVBW and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-23. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.